Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perloff

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
Psychological Bulletin|January 1, 1988
Biases resulting from the use of indexes: an application to attributional style and depressionJ M Perloff, J B Persons
The American Psychologist|December 18, 2013
Robert Perloff (1921-2013)Lewis P Lipsitt, Richard M Perloff
Medical and Pediatric Oncology|January 1, 1981
Cystosarcoma phylloides: a case presentationJ M Orsini, M Perloff, B Rybak
Cancer Chemotherapy Reports|May 1, 1974
Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancerM Perloff, F M Muggia, C Ackerman
Plos One|April 28, 2021
Does the U.S. Navy's reliance on objective standards prevent discrimination in promotions and retentions?Amos Golan, William H Greene, Jeffrey M Perloff
Cancer|October 1, 1981
One-day VATH (vinblastine, Adriamycin, thiotepa, and Halotestin) therapy for advanced breast cancer refractory to chemotherapyR D Hart, M Perloff, J F Holland
Medical and Pediatric Oncology|January 1, 1978
Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptivesP N Gattanell, M Perloff, J F Holland
Cancer|December 1, 1978
Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapyM Perloff, R D Hart, J F Holland
Current Problems in Cancer|April 1, 1986
Small cell bronchogenic carcinomaM Perloff, J Y Killen, R E Wittes
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Adjuvant therapy for breast cancer patients with negative lymph nodesM A Friedman, F A Dorr, M Perloff
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
Psychological Bulletin|January 1, 1988
Biases resulting from the use of indexes: an application to attributional style and depressionJ M Perloff, J B Persons
The American Psychologist|December 18, 2013
Robert Perloff (1921-2013)Lewis P Lipsitt, Richard M Perloff
Medical and Pediatric Oncology|January 1, 1981
Cystosarcoma phylloides: a case presentationJ M Orsini, M Perloff, B Rybak
Cancer Chemotherapy Reports|May 1, 1974
Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancerM Perloff, F M Muggia, C Ackerman
Plos One|April 28, 2021
Does the U.S. Navy's reliance on objective standards prevent discrimination in promotions and retentions?Amos Golan, William H Greene, Jeffrey M Perloff
Cancer|October 1, 1981
One-day VATH (vinblastine, Adriamycin, thiotepa, and Halotestin) therapy for advanced breast cancer refractory to chemotherapyR D Hart, M Perloff, J F Holland
Medical and Pediatric Oncology|January 1, 1978
Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptivesP N Gattanell, M Perloff, J F Holland
Cancer|December 1, 1978
Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapyM Perloff, R D Hart, J F Holland
Current Problems in Cancer|April 1, 1986
Small cell bronchogenic carcinomaM Perloff, J Y Killen, R E Wittes
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1986
Adjuvant therapy for breast cancer patients with negative lymph nodesM A Friedman, F A Dorr, M Perloff
Pageof 7